Non-invasive Intracranial Pressure (ICP) Measurement System Vittamed Corporation is a neurodiagnostic and monitoring device company located in Boston, MA (USA) with operations in Kaunas, Lithuania. The Company has developed an platform of products to non-invasively measure intracranial pressure and monitor cerebral autoregulation. Intracranial Pressure (ICP) is the leading indicator for the treatment of patients with TBI and neurological diseases. Prolonged increased ICP and impaired CA is associated with neurological and cognitive impairment and if left untreated could lead to death. Only invasive ICP monitoring is currently available, but it has limited usage due to the risks and costs associated with the invasive procedures (interventricular catheter and lumbar puncture). The non-invasive ICP system for Vittamed measures absolute ICP and has been clinically validated to work on all types of patients as well as proven to be accurate, precise and safe for patients. The Vittamed 205 ICP system and Vittamed 505 CA Autoregulation monitor have CE Mark approval. Downloads: Company Brochure Vittamed Brochure.pdf